Seraphim Space Investment Trust (SSIT) Share Price, News & Analysis

Company Overview

Seraphim Space Investment Trust Plc specializes in incubation, mid venture, late venture, later stage, PIPEs, and industry consolidation. It seeks to invest in space technology. The fund invests between $0.25 million to $25 million. Seraphim Space Investment Trust Plc was founded in 2021 and is headquartered in London, Greater London, United Kingdom.

Key Stats

• Today's Range: 54.01 to 54.58
• 50-Day Range: 46.37 to 55
• 52-Week Range: 32.50 to 75
• Volume: 226,597 shs
• Average Volume: 324,757 shs
• Market Capitalization: £128.11 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SSIT Stock Analysis - Frequently Asked Questions

How have SSIT shares performed this year?

Seraphim Space Investment Trust's stock was trading at GBX 34.40 at the beginning of 2024. Since then, SSIT shares have increased by 57.0% and is now trading at GBX 54.01.
View the best growth stocks for 2024 here.

How do I buy shares of Seraphim Space Investment Trust?

Shares of SSIT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Seraphim Space Investment Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Seraphim Space Investment Trust investors own include Haleon (HLN), PureTech Health (PRTC), Spire Healthcare Group (SPI), The Renewables Infrastructure Group (TRIG), Unilever (ULVR), City of London (CTY) and ChargePoint (CHPT).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:SSIT
• CUSIP: N/A
• CIK: N/A
• Web: www.seraphim.vc
• Phone: 1.775.284.0370
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 237,200,000
• Free Float: N/A
• Market Cap: £128.11 million
• Optionable: Not Optionable
• Beta: N/A